Guttman-McCabe Christopher bought ATEX
June 15, 2026 · Form 4 insider transaction
Guttman-McCabe Christopher bought 8,000 shares of Anterix Inc. at $32.50 per share, a transaction worth $260.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,000
Price
$32.50
Total value
$260.0K
InsiderGuttman-McCabe Christopher
Role—
CompanyAnterix Inc. (ATEX)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 15, 2026
Filing dateJune 17, 2026
Shares owned after66,142
OwnershipDirect
10b5-1 planNo
AmendedNo